Last Posted: Apr 11, 2019
- Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
Rhiem Kerstin et al. The breast journal 2019 Apr - Germline Genetic Testing: What the Breast Surgeon Needs to Know.
Plichta Jennifer K et al. Annals of surgical oncology 2019 Apr - Task-based assessment of a convolutional neural network for segmenting breast lesions for radiomic analysis.
Spuhler Karl D et al. Magnetic resonance in medicine 2019 Apr - Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Kurozumi Sasagu et al. Breast cancer research and treatment 2019 Apr - Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.
Lambertini Matteo et al. Reproductive biomedicine online 2019 Jan - Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy.
Menkiszak Janusz et al. Hereditary cancer in clinical practice 2019 1710 - Deep Learning Model to Assess Cancer Risk on the Basis of a Breast MR Image Alone.
Portnoi Tally et al. AJR. American journal of roentgenology 2019 Apr 1-7 - Women's cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics.
Murthy Pooja et al. Ecancermedicalscience 2019 13904 - A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
Veeraraghavan J et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Mar - American Society of Breast Surgeons Recommends Genetic Testing for Newly Diagnosed Patients With Breast Cancer,
by Caroline Helwick, The ASCO Post, March 25, 2019
.png)
No hay comentarios:
Publicar un comentario